drugset / Trial / NCT01980810
First Line Chemotherapy for Advanced Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether albumine-bounded paclitaxel plus S-1 are effective in the treatment of advanced gastric or gastroesophageal junction adenocarcinoma.
Timeline
- Start
- 2013-09
- Primary completion
- 2015-02
- Completion
- 2016-02
Outcome
Outcome not reported
Stopped (Enrollment): “recruit too slowly”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paclitaxel | Small molecule | 200 mg | Intravenous |
| Subject | S-1 | Small molecule | 40 mg/m2 | Oral |